Press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Nov 2, 2022
Ridgewood, NJ, November 2, 2022 – Valley-Mount Sinai Comprehensive Cancer Care is pleased to be the recipient of a $652,000 grant over three years from BD (Becton, Dickinson and Company), a...
-
Oct 26, 2022Conforms to Independently Audited International Standards for Information Security: ISO/IEC 27001:2022
FRANKLIN LAKES, N.J. (Oct. 26, 2022) – BD (Becton, Dickinson and Company), a leading global medical technology company, today announced its enterprise-level Information Security Management...
-
Oct 18, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Magnolia Medical Technologies, Inc., today announced a co-exclusive commercial agreement aimed at...
-
Oct 17, 2022BD, Biocorp Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable DrugsCompanies to Explore Opportunities to Integrate Biocorp’s Injay® Technology with BD UltraSafePlus™ Passive Needle Guard to Help Biopharmaceutical Manufacturers Capture and Transmit Self-Administered Injection Data.
FRANKLIN LAKES, N.J. (October 17, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biocorp, a medical device and delivery systems...
-
Oct 13, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will report its fiscal 2022 fourth quarter and full year financial results on Thursday, November 10, 2022. A news release...
-
Oct 11, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Forbes' 2022 list of the World's Best Employers. "Empowering our teams to excel in...
-
Oct 3, 2022
FRANKLIN LAKES, N.J. (Oct. 3, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Eric Borin has been named president of...
-
Sep 29, 2022
Public-Private Partnership Supporting Diagnostic Testing in Vulnerable Communities has Provided $2.6 Million to U.S. Clinics Since 2017 to Help Improve Patient Outcomes and Health Equity FRANKLIN...
-
Sep 27, 2022
Diagnostic Research Center Enables Students to Test and Develop Clinical Workflows to Help Shape Laboratory Performance and Patient Outcomes FRANKLIN LAKES, N.J., Sept. 27, 2022 /PRNewswire/ -- BD...
-
Sep 27, 2022
New BD® Research Cloud provides scientists with an integrated ecosystem that allows for optimizing panel design, collaboration and analysis FRANKLIN LAKES, N.J., Sept. 27, 2022 /PRNewswire/ -- BD...
-
Sep 26, 2022
Research Use Only (RUO) assay now globally available for BD MAX™ System FRANKLIN LAKES, N.J., Sept. 26, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global...
-
Sep 19, 2022
Announcement Made at Clinton Global Initiative 2022 Commits $360,000 to Support Nurses in Africa FRANKLIN LAKES, N.J., Sept. 19, 2022 /PRNewswire/ -- The BD Foundation, the philanthropic arm of...
-
Sep 13, 2022
BD EffivaxTM Glass Prefillable Syringe Features Enhanced Technology that Builds on Company's Decades of Expertise in the Prefillable Syringe Market and Supports Customers' Manufacturing Needs...
-
Sep 8, 2022
Puneet Sarin Named President of Medication Management Solutions Steve Conly Named President of Biosciences FRANKLIN LAKES, N.J. (Sept. 8, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX),...
-
Aug 25, 2022
Mike Garrison Named EVP and President, Medical segment Rick Byrd Named EVP and President, Interventional segment FRANKLIN LAKES, N.J., Aug. 25, 2022 /PRNewswire/ -- BD (Becton, Dickinson and...
-
Aug 24, 2022
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Wells Fargo 2022 Healthcare Conference on Wednesday,...
-
Aug 22, 2022
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the consideration payable in connection with its previously announced Tender Offers (as defined below) to purchase...
-
Aug 22, 2022
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced the early tender results for its previously announced Tender Offers (as defined below) to purchase for cash...
-
Aug 18, 2022
First patient enrollment in PREVISION trial marks opportunity to further advance the safety and performance of drug-coated balloon technology and aligns with the company’s commitment to...
-
Aug 15, 2022
Companies will work together to bring rapid antimicrobial identification and susceptibility diagnostics to more clinicians and patients worldwide FRANKLIN LAKES, N.J. and TUCSON, Ariz., Aug. 15,...
-
Aug 9, 2022
Companies combine key capabilities to advance flow cytometry as an essential companion diagnostic modality for cancer and other diseases FRANKLIN LAKES, N.J., Aug. 9, 2022 /PRNewswire/ -- BD...
-
Aug 8, 2022
Becton, Dickinson and Company (NYSE: BDX) (the "Company" or "BD") today announced that it has commenced tender offers to purchase for cash the debt securities issued by the Company listed in the...
-
Aug 8, 2022
Funding to Four Community Health Centers Advances Medication Management Programs for Vulnerable Patients Managing Chronic Disease FRANKLIN LAKES, N.J., Aug. 8, 2022 /PRNewswire/ -- BD (Becton,...
-
Aug 4, 2022
Revenue from continuing operations of $4.6 billion increased 0.7% as reported and 3.8% on currency-neutral basis Revenue from continuing operations driven by base revenue growth of 6.0% as...
-
Jul 28, 2022
Acquisition adds to company's recent growth in high-technology pharmacy solutions and further accelerates the company's commitment to Smart, Connected Care – offering a customizable platform to...